MAGEA3 and gastric cancer: Since MAGE‐A3 is specifically overexpressed in GC and is closely related to GC cells proliferation,22 then, if sitagliptin can exert anticancer effects by downregulating MAGE‐A3, it will provide a new therapeutic target for GC.